Persistence of SARS-CoV-2 Viral RNA in Nasopharyngeal Swabs after Death: An Observational Study.

SARS-CoV-2 autopsy medico-legal procedures pandemic

Journal

Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893

Informations de publication

Date de publication:
10 Apr 2021
Historique:
received: 24 03 2021
revised: 08 04 2021
accepted: 09 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 1 5 2021
Statut: epublish

Résumé

The aim of this study was to investigate the persistence of SARS-CoV-2 in post-mortem swabs of subjects who died from SARS-CoV-2 infection. The presence of the virus was evaluated post-mortem from airways of 27 SARS-CoV-2 positive patients at three different time points (T1 2 h; T2 12 h; T3 24 h) by real-time PCR. Detection of antibodies to SARS-CoV-2 was performed by Maglumi 2019-nCoV IgM/IgG chemiluminescence assay. SARS-CoV-2 viral RNA was still detectable in 70.3% of cases within 2 h after death and in 66,6% of cases up to 24 h after death. Our data showed an increase of the viral load in 78,6% of positive individuals 24 h post-mortem (T3) in comparison to that evaluated 2 h after death (T1). Noteworthy, we detected a positive T3 post-mortem swab (24 h after death) from 4 subjects who were negative at T1 (2 h after death). The results of our study may have an important value in the management of deceased subjects not only with a suspected or confirmed diagnosis of SARS-CoV-2, but also for unspecified causes and in the absence of clinical documentation or medical assistance.

Identifiants

pubmed: 33920259
pii: microorganisms9040800
doi: 10.3390/microorganisms9040800
pmc: PMC8103507
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Int J Mol Sci. 2020 Sep 22;21(18):
pubmed: 32971906
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Am J Forensic Med Pathol. 2002 Jun;23(2):107-22
pubmed: 12040252
Int J Legal Med. 2001;114(4-5):237-43
pubmed: 11355402
Nature. 2020 Nov;587(7835):534-535
pubmed: 33214725
J Med Virol. 2020 Apr;92(4):418-423
pubmed: 31967327
Open Biol. 2017 Jan;7(1):
pubmed: 28123054
J Forensic Leg Med. 2020 Jul;73:102000
pubmed: 32658758
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Euro Surveill. 2020 Aug;25(32):
pubmed: 32794447
Forensic Sci Med Pathol. 2020 Sep;16(3):471-476
pubmed: 32399755
J Clin Med. 2020 Jun 28;9(7):
pubmed: 32605192
Pathologica. 2020 Jun;112(2):64-77
pubmed: 32324727
Int J Legal Med. 2019 May;133(3):871-881
pubmed: 30167776
Nat Rev Microbiol. 2019 Mar;17(3):181-192
pubmed: 30531947
Virchows Arch. 2021 Feb;478(2):343-353
pubmed: 32815036

Auteurs

Francesca Servadei (F)

Anatomic Pathology, Department of Experimental Medicine, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.

Silvestro Mauriello (S)

Forensic Medicine, Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.

Manuel Scimeca (M)

Anatomic Pathology, Department of Experimental Medicine, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.
Nuclear Medicine, Department of Experimental Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
Saint Camillus International University of Health Sciences, Via di Sant'Alessandro, 8, 00131 Rome, Italy.

Bartolo Caggiano (B)

Forensic Medicine, Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.

Marco Ciotti (M)

Division of Clinical Biochemistry and Clinical Molecular Biology, Department of Experimental Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.

Lucia Anemona (L)

Anatomic Pathology, Department of Experimental Medicine, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.

Manuela Montanaro (M)

Anatomic Pathology, Department of Experimental Medicine, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.

Erica Giacobbi (E)

Anatomic Pathology, Department of Experimental Medicine, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.

Michele Treglia (M)

Forensic Medicine, Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.

Sergio Bernardini (S)

Division of Clinical Biochemistry and Clinical Molecular Biology, Department of Experimental Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.

Luigi Tonino Marsella (LT)

Forensic Medicine, Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.

Nicoletta Urbano (N)

Nuclear Medicine, Department of Biomedicine and Prevention, University of Rome "Tor Vergata", 00133 Rome, Italy.

Orazio Schillaci (O)

Nuclear Medicine, Department of Experimental Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.

Alessandro Mauriello (A)

Anatomic Pathology, Department of Experimental Medicine, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.
Tor Vergata Oncoscience Research (TOR), University of Rome "Tor Vergata", 00133 Rome, Italy.

Classifications MeSH